Key Finding
Acupoint therapy significantly improved cognitive function in mild cognitive impairment patients, with MoCA scores improving by 1.47 points and MMSE scores by 1.44 points compared to controls.
Researchers analyzed 24 studies involving 2,005 patients to determine whether acupuncture and acupoint therapy can help people with mild cognitive impairment (MCI), a condition that falls between normal aging and dementia. MCI affects memory, thinking skills, daily activities, and can include mood changes. The research team examined whether stimulating specific acupuncture points could improve cognitive function compared to health education, fake treatments, standard non-drug therapies, or medications. The results showed that acupoint therapy significantly improved cognitive test scores. Patients receiving acupoint therapy scored higher on both the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE), the two standard tests used to measure cognitive function. The improvements were seen when compared to health education, sham treatments, standard non-drug therapies, and oral medications. Auricular acupressure (stimulation of points on the ear) also improved patients' ability to perform daily activities. However, the studies had some limitations. Only nine of the 24 studies reported safety information, and the reporting varied widely, making it difficult to fully understand potential risks. Changes in biological markers were not significant. For patients with MCI, these findings suggest that acupuncture and acupoint therapy may offer meaningful benefits for cognitive function and could be considered as part of a comprehensive treatment approach. If you're considering acupuncture for cognitive concerns, seek treatment from a licensed acupuncturist with experience in treating cognitive impairment.
This systematic review and meta-analysis evaluated 24 RCTs comprising 2,005 MCI patients comparing acupoint therapy against various controls. Primary outcomes were MoCA and MMSE scores. Results demonstrated statistically significant improvements in cognitive function: MoCA scores improved by MD=1.47 (95% CI: 0.95-1.99, p<0.00001) and MMSE by MD=1.44 (95% CI: 1.03-1.86, p<0.00001) overall. Subgroup analyses showed superiority over health education (MoCA MD=2.63, MMSE MD=2.83), sham control (MoCA MD=0.94, MMSE MD=1.29), standard nonpharmacological treatments (MoCA MD=1.42, MMSE MD=1.09), and oral medications (MoCA MD=0.52, MMSE MD=0.91), but not blank controls. Auricular acupressure improved ADL scores. Biomarker changes were nonsignificant. Risk of bias was assessed using Cochrane RoB 2.0. Safety reporting was inadequate (only 9/24 studies), limiting conclusions about adverse events. Clinical takeaway: Acupoint therapy demonstrates modest but consistent cognitive benefits in MCI, warranting consideration as adjunctive treatment pending higher-quality safety data.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.